Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06937671 · ClinicalTrials.gov registry record · NA
Randomized Trial of Cold EMR Compared to Hybrid Cold EMR.
A NA study of Polyp of Colon and Endoscopic Mucosal Resection, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 194
- Enrollment target
- 2
- Study locations
NCT06937671: Recruiting NA study of Polyp of Colon and Endoscopic Mucosal Resection, sponsored by The Cleveland Clinic.
NCT06937671 is a NA study of Polyp of Colon and Endoscopic Mucosal Resection that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 194 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06937671, a NA study of Polyp of Colon and Endoscopic Mucosal Resection, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this randomized clinical trial is to learn if a combination of hot and cold EMR technique is associated with a lower risk of polyp recurrence without increasing the risk of complication when removing large polyps. Participants will undergo EMR and return for a follow-up endoscopy in 3-6 months to check for polyp recurrence.
Primary Outcome
Recurrence of polyps confirmed by biopsy at the site of EMR on follow-up colonoscopy
Conditions Studied
Interventions
- PROCEDURE Cold EMR
- PROCEDURE Hybrid EMR
Study Locations (2)
Florida
- Cleveland Clinic Weston - Weston
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06937671 shows while recruiting
NCT06937671 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Polyp of Colon appearing as the primary indexed condition, and to 2 interventions - of which Cold EMR is the first listed.
NCT06937671 reports a single indexed study location in Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06937671 about?
NCT06937671 is a clinical study titled "Randomized Trial of Cold EMR Compared to Hybrid Cold EMR.". The goal of this randomized clinical trial is to learn if a combination of hot and cold EMR technique is associated with a lower risk of polyp recurrence without increasing the risk of complication when removing large polyps. Participants will undergo EMR and return for a follow-up endoscopy in 3-6...
What is the current status of trial NCT06937671?
This trial is currently recruiting. It is a NA study. The enrollment target is 194 participants. The study started on 2025-05-01. Estimated completion is 2026-12.
What conditions does trial NCT06937671 study?
This clinical trial studies the following conditions: Polyp of Colon, Endoscopic Mucosal Resection.
What interventions are being tested in trial NCT06937671?
The interventions under investigation include: Cold EMR (PROCEDURE), Hybrid EMR (PROCEDURE).
Who is sponsoring clinical trial NCT06937671?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06937671 being conducted?
This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06937671's enrollment target sits among peer trials
194 568th of 2000 higher than 1,432 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI